Papers

7

Total Citations

92

H-Index

4

About

Matteo Salvi is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney and prostate diseases. His major contributions lie in refining robot-assisted procedures to improve both oncologic and functional outcomes. He pioneered the "Endoscopic robot-assisted simple enucleation (ERASE)" technique for renal masses, demonstrating its safety and efficacy in a 2014 study (38 citations). Salvi has also made significant strides in benign prostatic hyperplasia treatment, comparing en-bloc Holmium laser enucleation (HoLEP) with robot-assisted simple prostatectomy (27 citations, 2023). His research extends to challenging scenarios, such as managing renal stones in pelvic ectopic kidneys (16 citations, 2020) and assessing the safety of delaying prostate cancer surgery (2024). Notably, his work on robot-assisted partial nephrectomy in solitary kidneys (2025) highlights his focus on preserving renal function. With a growing portfolio that includes predictive models for prostate cancer risk, Salvi’s impact is marked by his commitment to evidence-based, patient-tailored surgical care, making him a key voice in modern urologic oncology.

Research Focus

Key Achievements

4
H-Index
7
Papers
92
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results
38 citations · 2014
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 51
🏛 Institutions: University of Florence, Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago